Cabio Biotech (Wuhan) Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: CNE100005X31
CNY
22.89
-0.08 (-0.35%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
550.15
437.42
428.87
346.10
318.86
306.47
279.86
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
550.15
437.42
428.87
346.10
318.86
306.47
279.86
Raw Material Cost
321.13
261.55
255.55
179.07
148.56
149.80
149.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
44.95
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.57
0.77
1.41
0.44
0.05
0.09
0.08
Selling and Distribution Expenses
63.82
60.60
77.87
46.73
43.90
41.88
38.63
Other Expenses
4.34
3.47
2.82
2.83
1.86
1.69
-3.03
Total Expenditure (Excl Depreciation)
428.91
357.61
363.05
254.54
211.09
208.65
202.64
Operating Profit (PBDIT) excl Other Income
121.19999999999999
79.80000000000001
65.8
91.6
107.8
97.8
77.2
Other Income
36.32
37.19
63.92
56.92
56.72
51.40
42.54
Operating Profit (PBDIT)
197.86
155.56
151.71
177.03
183.07
169.88
142.18
Interest
0.57
0.77
1.41
0.44
0.05
0.09
0.08
Exceptional Items
0.27
-2.64
-37.80
0.99
3.02
0.00
-0.46
Gross Profit (PBDT)
229.02
175.88
173.32
167.03
170.30
156.67
130.61
Depreciation
58.49
50.07
27.58
24.04
26.01
28.98
27.84
Profit Before Tax
139.07
102.08
84.93
153.54
160.02
140.82
113.80
Tax
19.69
13.63
16.56
20.77
22.80
20.00
15.97
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
124.21
91.37
64.37
128.58
130.59
118.17
96.99
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
124.21
91.37
64.37
128.58
130.59
118.17
96.99
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-4.08
-5.01
-2.79
2.72
4.35
1.58
0.84
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
120.13
86.37
61.58
131.29
134.94
119.75
97.83
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,556.09
1,476.35
1,418.93
1,381.02
1,317.93
1,248.34
526.54
Earnings per share (EPS)
0.74
0.54
0.38
0.77
0.78
0.7
0.58
Diluted Earnings per share
0.74
0.54
0.38
0.77
0.78
0.7
0.58
Operating Profit Margin (Excl OI)
18.73%
15.61%
14.04%
27.76%
31.47%
29.2%
25.65%
Gross Profit Margin
35.91%
34.78%
26.23%
51.31%
58.34%
55.4%
50.61%
PAT Margin
22.58%
20.89%
15.01%
37.15%
40.95%
38.56%
34.65%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 25.77% vs 1.98% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 39.00% vs 40.26% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 36.40% vs 34.85% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -25.00% vs -42.86% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Cabio Biotech (Wuhan) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
550.15
0
550.15
Other Operating Income
0.00
0.00
0.00
Total Operating income
550.15
0
550.15
Raw Material Cost
321.13
0
321.13
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.57
0
0.57
Selling and Distribution Expenses
63.82
0
63.82
Other Expenses
4.34
0.00
4.34
Total Expenditure (Excl Depreciation)
428.91
0
428.91
Operating Profit (PBDIT) excl Other Income
121.23
0.00
121.23
Other Income
36.32
0
36.32
Operating Profit (PBDIT)
197.86
0
197.86
Interest
0.57
0
0.57
Exceptional Items
0.27
0
0.27
Gross Profit (PBDT)
229.02
0
229.02
Depreciation
58.49
0
58.49
Profit Before Tax
139.07
0
139.07
Tax
19.69
0
19.69
Provisions and contingencies
0
0
0.00
Profit After Tax
124.21
0
124.21
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
124.21
0
124.21
Share in Profit of Associates
0
0
0.00
Minority Interest
-4.08
0
-4.08
Other related items
0.00
0.00
0.00
Consolidated Net Profit
120.13
0
120.13
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,556.09
0
1,556.09
Earnings per share (EPS)
0.74
0
0.74
Diluted Earnings per share
0.74
0
0.74
Operating Profit Margin (Excl OI)
18.73%
0%
0.00
18.73%
Gross Profit Margin
35.91%
0%
0.00
35.91%
PAT Margin
22.58%
0%
0.00
22.58%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 55.01 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 25.77% vs 1.98% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 12.01 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 39.00% vs 40.26% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.15 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 36.40% vs 34.85% in Dec 2023

Annual - Interest
Interest 0.06 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -25.00% vs -42.86% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.73%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023